Teva Pharmaceutical Industries

Complex generics will boost speciality biz, Teva says

Complex generics will boost speciality biz, Teva says

By Dan Stanton

Complex generics will represent over 50% of Teva’s generic market by 2017, the firm says, but investments in delivery technology will have positive implications across the full business.

France Probes Mislabelled Teva Heart Drug After Death

France Probes Mislabelled Teva Heart Drug

By Gareth Macdonald

French authorities are investigating if a packaging mix-up at generics giant Teva Pharmaceutical Industries played a role in the death of a man in Marseilles last week.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers